BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27551980)

  • 21. Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited.
    Keser G; Aksu K; Direskeneli H
    Rheumatology (Oxford); 2018 May; 57(5):784-790. PubMed ID: 28968895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018.
    Aydin SZ; Robson JC; Sreih AG; Hill C; Alibaz-Oner F; Mackie S; Beard S; Gul A; Hatemi G; Kermani TA; Mahr A; Meara A; Milman N; Shea B; Tómasson G; Tugwell P; Direskeneli H; Merkel PA
    J Rheumatol; 2019 Sep; 46(9):1198-1201. PubMed ID: 30877212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large vessel vasculitides: update for the cardiologist.
    Luqmani R
    Curr Opin Cardiol; 2012 Nov; 27(6):578-84. PubMed ID: 23032715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Takayasu and giant cell (temporal) arteritis: the concealed realities].
    Alat I; Bahçeci F; Taşkapan H; Saraç K
    Anadolu Kardiyol Derg; 2004 Dec; 4(4):351-3. PubMed ID: 15590368
    [No Abstract]   [Full Text] [Related]  

  • 25. [Vasculitis of the large arteries].
    Schmidt JA; von Bierbrauer A; von Wichert P
    Internist (Berl); 1993 Jul; 34(7):615-21. PubMed ID: 8103509
    [No Abstract]   [Full Text] [Related]  

  • 26. Outcome assessment in Takayasu arteritis.
    Nakagomi D; Jayne D
    Rheumatology (Oxford); 2016 Jul; 55(7):1159-71. PubMed ID: 26472566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The fine line between Takayasu arteritis and giant cell arteritis.
    Polachek A; Pauzner R; Levartovsky D; Rosen G; Nesher G; Breuer G; Anouk M; Arad U; Sarvagyl-Maman H; Kaufman I; Caspi D; Elkayam O
    Clin Rheumatol; 2015 Apr; 34(4):721-7. PubMed ID: 25416136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large-vessel vasculitis.
    Pugh D; Karabayas M; Basu N; Cid MC; Goel R; Goodyear CS; Grayson PC; McAdoo SP; Mason JC; Owen C; Weyand CM; Youngstein T; Dhaun N
    Nat Rev Dis Primers; 2022 Jan; 7(1):93. PubMed ID: 34992251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Giant cell and Takayasu arteritis.
    Seko Y
    Curr Opin Rheumatol; 2007 Jan; 19(1):39-43. PubMed ID: 17143094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update.
    Pipitone N; Versari A; Salvarani C
    Rheumatology (Oxford); 2008 Apr; 47(4):403-8. PubMed ID: 18292120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Non-infectious diseases of the aorta and large arteries].
    Beketova TV
    Ter Arkh; 2022 Jun; 94(5):695-703. PubMed ID: 36286971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical study of giant cell arteritis in our hospital].
    Suematsu E; Miyamura T; Nakamura M; Higuchi M; Mori S; Iwanaga T; Kaku Y; Takahama S; Minami R; Yamamoto M
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(6):466-72. PubMed ID: 27118334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathology of large-vessel vasculitides.
    Miller DV; Maleszewski JJ
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S92-8. PubMed ID: 21586202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory Diseases of the Aorta: JACC Focus Seminar, Part 2.
    Kadian-Dodov D; Seo P; Robson PM; Fayad ZA; Olin JW
    J Am Coll Cardiol; 2022 Aug; 80(8):832-844. PubMed ID: 35981827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cough as a clinical manifestation of large vessel vasculitis.
    Azzam O; Hubble D; Prentice D
    Intern Med J; 2022 Mar; 52(3):488-490. PubMed ID: 35307929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standard and biological treatment in large vessel vasculitis: guidelines and current approaches.
    Muratore F; Pipitone N; Salvarani C
    Expert Rev Clin Immunol; 2017 Apr; 13(4):345-360. PubMed ID: 28116918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EULAR recommendations for the management of large vessel vasculitis.
    Mukhtyar C; Guillevin L; Cid MC; Dasgupta B; de Groot K; Gross W; Hauser T; Hellmich B; Jayne D; Kallenberg CG; Merkel PA; Raspe H; Salvarani C; Scott DG; Stegeman C; Watts R; Westman K; Witter J; Yazici H; Luqmani R;
    Ann Rheum Dis; 2009 Mar; 68(3):318-23. PubMed ID: 18413441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides.
    Tombetti E; Hysa E; Mason JC; Cimmino MA; Camellino D
    Curr Rheumatol Rep; 2021 Feb; 23(3):17. PubMed ID: 33569633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis.
    Águeda AF; Monti S; Luqmani RA; Buttgereit F; Cid M; Dasgupta B; Dejaco C; Mahr A; Ponte C; Salvarani C; Schmidt W; Hellmich B
    RMD Open; 2019; 5(2):e001020. PubMed ID: 31673416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Rare Case of Takayasu Arteritis With Intracranial Involvement, Aortic Valvulitis, and Giant Cell Aortitis.
    Edwards SL; Baker V; Boswell GE; Butts MS
    J Clin Rheumatol; 2021 Dec; 27(8S):S598-S602. PubMed ID: 30601198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.